Advancing Donor Diversity & Retention, with Improved Screening, Biomarker Identification & Welfare Management for Scalable Allogeneic Drug Development
Event Dates
2024-11-18 - 2024-11-20
Organizer
Exhibitors
25
Floor Size
0
Attendees
100
Event contact title
Contact
Event contact first name
.
Event contact last name
.
Email
info@hansonwade.com
Event contact telephone number
UK: +44 (0)20 3141 8700 / US: +1 617 455 4188
Description
The ONLY Meeting Keeping Donors at the Heart of the Conversation
It is known that suboptimal donor selection in allogeneic therapies can compromise treatment efficacy and patient safety. Raising the question: are our current donor selection criteria robust enough to meet the growing demands and challenges in this critical field?
As the clinical landscape for allogeneic therapies continues to evolve, the challenging reality of achieving true scalability is setting in for the field, with all eyes turning to the backbones of these universal therapies to ensure a high-quality and scalable product can be achieved through a well-thought-out donor plan.